Virpax Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGVirpax Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 34), showing significant lag compared to the market leaders. Earnings growth of 79% provides fundamental context to the price action. However, price is extended 178% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.00 | +141.30% | ABOVE |
| 50 SMA | $0.00 | +177.50% | ABOVE |
| 100 SMA | $0.01 | +60.87% | ABOVE |
| 150 SMA | $0.01 | -3.48% | BELOW |
| 200 SMA | $0.01 | -10.48% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is VRPX in an uptrend right now?
VRPX has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is VRPX overbought or oversold?
VRPX's RSI (14) is 72. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is VRPX outperforming the market?
VRPX has a Relative Strength (RS) Rating of 34 out of 99. VRPX is currently lagging the broader market.
Where is VRPX in its 52-week range?
VRPX is trading at $0.01, which is 2% of its 52-week high ($0.46) and 2% above its 52-week low ($0.00).
How volatile is VRPX?
VRPX has a Beta of -0.28 and 52-week volatility of 379%. It's less volatile than the S&P 500 - generally more stable.